PRESS RELEASE published on 04/29/2025 at 13:51, 1 year 4 months ago Informations privilégiées / Autres communiqués Arkema annonce avoir réalisé des achats d'actions propres conformément à la réglementation en vigueur. Consultez le site web pour plus d'informations Transactions Réglementation Investisseurs Achats D'actions ARKEMA
BRIEF published on 04/28/2025 at 09:24, 1 year 4 months ago Franchissement de seuil par BlackRock dans ARKEMA Franchissement De Seuil BlackRock Gestion D'actifs ARKEMA Marché Actions
BRIEF published on 04/28/2025 at 09:24, 1 year 4 months ago BlackRock crosses the threshold in ARKEMA Asset Management Stock Market BlackRock Threshold Crossing ARKEMA
BRIEF published on 04/28/2025 at 09:22, 1 year 4 months ago BlackRock franchit à la baisse le seuil de 5% dans ARKEMA Capital Droits De Vote Franchissement De Seuil BlackRock ARKEMA
BRIEF published on 04/28/2025 at 09:22, 1 year 4 months ago BlackRock crosses the 5% threshold in ARKEMA Voting Rights Capital BlackRock Threshold Crossing ARKEMA
PRESS RELEASE published on 04/28/2025 at 09:19, 1 year 4 months ago Franchissement de seuil Declaration de franchissement de seuil de la société ARKEMA par BlackRock Inc. pour le compte de clients et fonds, détenant 5,04% du capital et 4,03% des droits de vote Franchissement De Seuil BlackRock Inc. ARKEMA 5,04% 4,03%
PRESS RELEASE published on 04/28/2025 at 09:17, 1 year 4 months ago Franchissement de seuil Déclaration de franchissement de seuil par BlackRock Inc. pour ARKEMA le 23 avril 2025. Détention de 4,92% du capital et 3,93% des droits de vote Capital Droits De Vote Franchissement De Seuil BlackRock Inc. ARKEMA
BRIEF published on 04/22/2025 at 12:17, 1 year 4 months ago Arkema publie ses transactions d'actions propres Transactions D'actions Prix Moyen Règlement UE ARKEMA Avril 2025
BRIEF published on 04/22/2025 at 12:17, 1 year 4 months ago Arkema publishes its own share transactions EU Regulation Stock Transactions Average Price ARKEMA April 2025
PRESS RELEASE published on 04/22/2025 at 12:12, 1 year 4 months ago Informations privilégiées / Autres communiqués Arkema déclare les transactions sur actions propres réalisées du 14 au 17 avril 2025, conformément à la réglementation, totalisant 12 000 actions achetées Transactions Sur Actions Propres Réglementation Investisseurs Rachats D'actions ARKEMA
Published on 09/11/2026 at 04:00, 8 hours 15 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 13 hours 50 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 20 hours 55 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 21 hours 15 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 11:43, 32 minutes ago Skyborn reaches Financial Close on the Gennaker offshore wind farm project
Published on 09/11/2026 at 11:35, 40 minutes ago EQS-Adhoc: Correction of a release from 10/09/2026, 19:35 CET/CEST - United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
Published on 09/11/2026 at 11:30, 45 minutes ago Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
Published on 09/11/2026 at 10:15, 2 hours ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 07:00, 5 hours 15 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 5 hours 15 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 5 hours 15 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 16 hours 45 minutes ago Availability of the 2026 Interim Financial Report
